Paper351504
Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.
Boger WP and 3 others. Ophthalmology, 1978. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Papers, record 351504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/351504
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glaucoma | Major topic |
| Propanolamines | Major topic |
| Timolol | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Depression, Chemical | |
| Evaluation Studies as Topic | |
| Follow-Up Studies | |
| Humans | |
| Intraocular Pressure | |
| Ophthalmic Solutions | |
| Pulse |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41466900 | Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma. | Cureus | 2025 | https://conductscience.org/library/papers/41466900 | PubMed |
| 38082203 | Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance. | Handb Exp Pharmacol | 2024 | https://conductscience.org/library/papers/38082203 | PubMed |
| 32440086 | Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination. | Clin Ophthalmol | 2020 | https://conductscience.org/library/papers/32440086 | PubMed |
| 30794789 | Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes. | Am J Ophthalmol | 2019 | https://conductscience.org/library/papers/30794789 | PubMed |
| 25061275 | Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/25061275 | PubMed |
| 21681417 | Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration. | Jpn J Ophthalmol | 2011 | https://conductscience.org/library/papers/21681417 | PubMed |
| 21052902 | Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma. | Jpn J Ophthalmol | 2010 | https://conductscience.org/library/papers/21052902 | PubMed |
| 19668385 | Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). | Clin Ophthalmol | 2008 | https://conductscience.org/library/papers/19668385 | PubMed |
| 17041807 | Topical drug therapy in glaucoma. | Wien Med Wochenschr | 2006 | https://conductscience.org/library/papers/17041807 | PubMed |
| 10776828 | Pharmacological therapy for glaucoma: a review. | Drugs | 2000 | https://conductscience.org/library/papers/10776828 | PubMed |
| 10655195 | Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group. | Br J Ophthalmol | 2000 | https://conductscience.org/library/papers/10655195 | PubMed |
| 7398530 | Timolol eye drops: bradycardia or tachycardia? | Doc Ophthalmol | 1980 | https://conductscience.org/library/papers/7398530 | PubMed |
| 7387959 | Timolol in operated closed-angle glaucoma. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7387959 | PubMed |
| 7363532 | Absorption of ocular timolol. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7363532 | PubMed |
| 7216626 | Effects of timolol on corneal sensitivity and tear production. | Int Ophthalmol | 1980 | https://conductscience.org/library/papers/7216626 | PubMed |
| 7075965 | The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7075965 | PubMed |
| 7039666 | Dose response of oral timolol combined with adrenaline. | Br J Ophthalmol | 1982 | https://conductscience.org/library/papers/7039666 | PubMed |
| 7028085 | Study of the additive effect of timolol and epinephrine in lowering intraocular pressure. | Br J Ophthalmol | 1981 | https://conductscience.org/library/papers/7028085 | PubMed |
| 7004479 | Interaction of timolol and adrenaline. | Br J Ophthalmol | 1981 | https://conductscience.org/library/papers/7004479 | PubMed |
| 6909025 | Dose-related interaction between timolol and adrenaline. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1981 | https://conductscience.org/library/papers/6909025 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/351504
GET https://conductscience.org/api/papers/v1/351504/cited_by?page=2